The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis.

BMC Med · 2016 · PMC4916534 · PMID 27328975

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Secondary patient outcomes None of the secondary outcomes were significantly different between intervention and control groups, though anxiety ( p = 0.08) and depression ( p = 0.06) measured by the HADS were of borderline significance in favour of the CARE Plus group, although the effects sizes were relatively small.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.